Gastroenterology
Acute Diarrhea
15
Pipeline Programs↗
1
Active Trials↗
4
Companies Involved↗
Acute Diarrhea is an emerging landscape with 15 programs across 4 companies. The most active players are Johnson & Johnson, Pfizer, Sanofi. 5 therapies are approved with 6 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical3
Phase 1
No programs
Phase 21
Phase 36
Analysis
Trial Status
17
clinical trials
Completed15 · 88%
Unknown status1 · 6%
Recruiting1 · 6%
Clinical Trials
Trial Activity
17 trials
Zinc Plus Saccharomyces Boulardii Versus Zinc Alone in the Treatment of Acute Diarrhea
Completed·—·N/A·NCT07168304·276 enrolled
Oral Zinc for the Treatment of Acute Diarrhea in US Children
Completed·—·N/A·NCT01198587·71 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)